DR AGARWALS HEALTH CARE
|
DR AGARWALS HEALTH CARE Last 5 Year Financial Ratios History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 4.20 | 2.64 | 89.02 | 118.72 | 54.95 |
| CEPS(Rs) | 14.03 | 10.80 | 9.48 | 9.74 | 6.84 |
| DPS(Rs) | - | - | - | - | - |
| Book NAV/Share(Rs) | 63.55 | 58.77 | 1,428.99 | 791.99 | 309.59 |
| Tax Rate(%) | 32.38 | 30.97 | 32.38 | -23.49 | 23.96 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 27.46 | 26.39 | 27.18 | 26.51 | 26.10 |
| EBIT Margin(%) | 16.67 | 16.07 | 18.10 | 15.73 | 15.19 |
| Pre Tax Margin(%) | 11.95 | 9.34 | 10.55 | 8.21 | 8.15 |
| PAT Margin (%) | 8.08 | 6.45 | 7.14 | 10.14 | 6.20 |
| Cash Profit Margin (%) | 21.36 | 19.93 | 19.92 | 22.74 | 20.23 |
| Performance Ratios | |||||
| ROA(%) | 4.45 | 3.47 | 4.24 | 7.42 | 4.83 |
| ROE(%) | 8.69 | 6.92 | 9.69 | 24.58 | 21.77 |
| ROCE(%) | 16.14 | 14.32 | 17.77 | 21.51 | 24.26 |
| Asset Turnover(x) | 0.55 | 0.54 | 0.59 | 0.73 | 0.78 |
| Sales/Fixed Asset(x) | 0.58 | 0.59 | 0.64 | 0.71 | 0.72 |
| Working Capital/Sales(x) | 18.66 | 5.50 | 3.71 | 114.88 | 32.41 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 1.72 | 1.69 | 1.57 | 1.41 | 1.39 |
| Receivable days | 24.96 | 23.51 | 23.72 | 23.85 | 27.12 |
| Inventory Days | 15.29 | 14.10 | 12.05 | 12.36 | 15.94 |
| Payable days | 261.47 | 292.62 | 312.42 | 306.23 | 356.83 |
| Valuation Parameters | |||||
| PER(x) | 96.61 | 169.15 | - | - | - |
| PCE(x) | 28.95 | 41.39 | - | - | - |
| Price/Book(x) | 6.39 | 7.60 | - | - | - |
| Yield(%) | - | - | - | - | - |
| EV/Net Sales(x) | 6.20 | 8.25 | 0.20 | 0.21 | 0.26 |
| EV/Core EBITDA(x) | 20.74 | 27.74 | 0.66 | 0.75 | 0.89 |
| EV/EBIT(x) | 37.20 | 51.32 | 1.13 | 1.35 | 1.71 |
| EV/CE(x) | 5.91 | 6.68 | 0.16 | 0.22 | 0.36 |
| M Cap / Sales | 6.19 | 8.25 | - | - | - |
| Growth Ratio | |||||
| Net Sales Growth(%) | 21.57 | 28.44 | 30.86 | 46.25 | 47.73 |
| Core EBITDA Growth(%) | 22.17 | 23.65 | 42.68 | 41.77 | 124.82 |
| EBIT Growth(%) | 26.05 | 14.07 | 50.61 | 51.37 | 2,580.75 |
| PAT Growth(%) | 52.38 | 16.09 | -7.92 | 139.16 | 173.94 |
| EPS Growth(%) | 59.13 | -97.03 | -25.01 | 116.06 | 167.94 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 0.08 | 0.13 | 0.29 | 0.57 | 1.37 |
| Current Ratio(x) | 1.24 | 1.65 | 1.90 | 1.03 | 1.10 |
| Quick Ratio(x) | 1.04 | 1.48 | 1.77 | 0.91 | 0.94 |
| Interest Cover(x) | 3.54 | 2.39 | 2.40 | 2.09 | 2.16 |
| Total Debt/Mcap(x) | 0.01 | 0.02 | - | - | - |
Compare Financial Ratios of peers of DR AGARWALS HEALTH CARE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DR AGARWALS HEALTH CARE | ₹14,770.6 Cr | -2% | -7.7% | -10.2% | Stock Analytics | |
| APOLLO HOSPITALS ENTERPRISE | ₹113,547.0 Cr | 1.2% | -9.4% | 3.3% | Stock Analytics | |
| MAX HEALTHCARE INSTITUTE | ₹82,244.7 Cr | -2.8% | -18.2% | -25.9% | Stock Analytics | |
| ASTER DM HEALTHCARE | ₹58,733.3 Cr | -1.2% | -9.1% | -0.5% | Stock Analytics | |
| FORTIS HEALTHCARE | ₹55,659.3 Cr | -2.7% | -15.1% | -30.2% | Stock Analytics | |
| NARAYANA HRUDAYALAYA | ₹35,120.4 Cr | 1.4% | -7.2% | -2.7% | Stock Analytics | |
DR AGARWALS HEALTH CARE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DR AGARWALS HEALTH CARE | -2% |
-7.7% |
-10.2% |
| SENSEX | 3.1% |
1% |
-9.1% |
You may also like the below Video Courses
